Ratio Therapeutics, Inc. (Ratio), a clinical-stage pharmaceutical company developing best-in-class radiopharmaceuticals for cancer treatment, announced the closing of a $70 million Series C financing. The financing included strong participation from existing investors Duquesne Family Office and Bristol Myers Squibb, …
Kaigene, Inc., a U.S.-based biotechnology company pioneering next-generation antibody therapeutics for autoimmune disorders, announced that it has entered into an exclusive licensing agreement with Taisho Pharmaceutical Co., Ltd. ("Taisho"), a leading Japanese pharmaceutical company, for the exclusive development and …
IMPACT Therapeutics is pleased to announce that it has entered into an exclusive partnership with Pharmanovia, a global specialty pharmaceutical company which partners with innovative biotech and large pharma to bring innovative specialty medicines to patients, to grant Pharmanovia the exclusive rights to manufacture,…
Ember LifeSciences, Inc., an award-winning provider of advanced pharmaceutical cold chain solutions, has entered into a capital and business alliance with Alfresa Corporation "Alfresa", a subsidiary of Alfresa Holdings Corporation. The Alfresa Group has the No. 1 domestic net sales in the pharmaceutical wholesale bus…
Excedr, Inc., a leading provider of full-service laboratory equipment leasing solutions for the life sciences and healthcare industries, announced the closing of $25 million in growth capital. The round includes a $17 million senior credit facility from BOK Financial and $8 million in equity from existing investors an…
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, announced that it has entered into a strategic collaboration with China National Pharmaceutical Group Co., Ltd.. The two parties will establish the Sinop…
The Agency for Science, Technology and Research (A*STAR), Singapore’s lead public sector R&D agency, and CuspAI, the frontier AI materials science company, announced a five-year, multi-programme partnership. The collaboration aims to accelerate the discovery and experimental validation of new materials across semi…
Care Career, a rapidly growing healthcare workforce technology organization, announced the acquisition of MAS Medical Staffing, one of the Northeast's leading healthcare workforce organizations. Financial terms of the transaction were not disclosed. The acquisition represents Care Career's seventh strategic acquisiti…
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, and BioLife Solutions, Inc. , a leading developer and supplier of cell processing tools and services for the cell and gene therapy (“CGT”) market, announced they have entered into a definitive agreement under which Repligen, …
AstraZeneca has entered into an exclusive license agreement with Dizal Pharmaceutical Co., Ltd for Zegfrovy (sunvozertinib), a novel oral irreversible epidermal growth factor receptor (EGFR) inhibitor for patients with lung cancer. AstraZeneca will acquire worldwide rights to develop and commercialise Zegfrovy. Dave …
Page 2 of 37